One of the most common MET oncogenic mutations, occurring in approximately 5% of non-small cell lung cancer, falls outside of the KD and results in skipping of exon 14, which encodes the N-terminal half of the MET intracellular juxtamembrane (JM) domain [26–29]. The gene discussed is MET; the disease is non-small cell lung carcinoma.